TrialAlzheimer's research & therapy2018

Data-driven identification of endophenotypes of Alzheimer's disease progression: implications for clinical trials and therapeutic interventions.

Nophar Geifman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.